2016 Round Table

ALGERIA 2020 & Biotechnology: What future & model for Algeria?

2016 roundtables

The need to communicate a clear vision, a political decision set out with a roadmap and concrete projects in the short, medium and long terms..

The presence of a dedicated interlocutor and decision-maker who would be the vis-à-vis the different actors for the biotechnology project like biopolis in Singapore

The importance of government incentive programs to encourage the private sector to invest, build a real biotechnology industry and encourage research in Algeria.

download

Audience

  • Director General of Pharmacy, MOH, Dr. Hamou Hafed
  • Director General of Health, MOH, Pr. Mohamel l’Hadj
  • General Manager of PCH, M’hamed Ayad
  • Director General of Social Security, Djaouad Bourkaib & Dr. Mohamed Lamine Ghanem
  • Director of INSP, Pr. Mokhtar Hasbellaoui
  • Senior management of companies & healthcare sector representative : Novo Nordisk, AstraZeneca, Clinica Group, Merck, ANPP, Deloitte, Sevier
  • Director Geenral of the Biotechnology Center

Attending Experts

Dr. Siew Hwa ONG

Founder & CEO, Acumen Research Laboratories & Chairman

Dra.C. Mayra Ramos Suzarte

Deepanwita Chattopadhyay

CEO & Chairman IKP Knowledge Park

Miquel Bonachera Sierra

CEO AB Bioticts, for ASEBIO
en_US
en_US fr_FR